All Cases

Biopharma

Built a geographic view of the treatment landscape for familial hypercholesterolemia to understand treatment adoption and inform our biotech client’s action plan and resourcing requirements

Identification of emerging market launch scenarios with highest success probability for a large pharmaceutical company 

Investigated adoption pain points for an appetite suppressant and their impact on adoption / adherence to underpin financial modeling and inform strategic commercialization investment at a small biotech

Identification of stakeholder-specific value propositions for a mid-size pharma company launching a therapy for a Lupus

Evaluated the global strategic launch plan and tailored it to fit the needs of the local marketplace, maximizing the patient pool touched by commercialization efforts

Assessed challenges to improve the quality of multiple sclerosis care in LATAM for a large pharmaceutical company looking to publish a position paper to guide the improvement of care for these patients

Developed regional market access strategies in several emerging markets to ensure strong market access for our multinational pharmaceutical company client

Estimated NSCLC burden in Mexico based on RWE to inform clinical management and drive market share of more effective therapies

Companion diagnostic strategy for launch of novel biomarker-driven oncology drug

Prioritization of tumor types for a tumor agnostic oncology asset to focus promotional efforts